PAVmed (PAVM) EBT Margin Growth (3y) (2024 - 2025)

PAVmed (PAVM) EBT Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -305.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -9.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -222.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -176.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 329.00
10 PAVmed 2.70 Mn -10.47 Mn -703,000.00 1.85 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.85 Mn
Sep 30, 2025 -8.08 Mn
Mar 31, 2025 24.32 Mn
Dec 31, 2024 1.80 Mn